BELLUS Health Inc. (BLU) |
| 14.745 0.005 (0.03%) 06-28 15:59 |
| Open: | 14.74 |
| High: | 14.75 |
| Low: | 14.74 |
| Volume: | 2,839,350 |
| Market Cap: | 1,870(M) |
| PE Ratio: | -20.2 |
| Exchange: | NASDAQ Global Select |
| Industry: | Biotechnology |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 66.84 |
| Resistance 1: | 57.23 |
| Pivot price: | 55.04 |
| Support 1: | 54.12 |
| Support 2: | 52.21 |
| 52w High: | 14.76 |
| 52w Low: | 6.38 |
BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. The company was incorporated in 1993 and is based in Laval, Canada.
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Thu, 29 Jun 2023
BLU Price History for Bellus Health Stock - Barchart.com
Tue, 16 May 2023
BELLUS Health Inc. Calls Special Shareholders’ Meeting in Connection with GSK Acquisition - FinancialContent
Fri, 12 May 2023
BELLUS Health Reports First Quarter 2023 Financial Results and Business Highlights - Business Wire
Tue, 18 Apr 2023
GSK bets $2 bln on Bellus cough drug to soothe pipeline fears - Reuters
Tue, 18 Apr 2023
GSK reaches agreement to acquire late-stage biopharmaceutical company BELLUS Health - GSK US
Wed, 05 Apr 2023
BELLUS Health Announces Positive Results from its Phase 1 Bioavailability Equivalence Study Evaluating Once-Daily Extended-Release Formulation of Camlipixant in Comparison to Twice-Daily Immediate Release Formulation - Business Wire
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |